Section

Is this Jhunjhunwala-backed pharma stock still a buy after 30% correction?

By Business Today - 2 days ago
Rekha Rakesh Jhunjhunwala, through multiple discretionary trusts, owned 25,199,240 equity shares, or 24.09 per cent stake in Concord Biotech as of September 30, 2024.

Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.